MaxCyte (MXCT) presentation at ShareSoc July 2018
Driving the next generation of cell-based medicines By Doug Doerfler – Founder, President & CEO Introduction – 00:23 Background and what MaxCyte does – 02:41 Business model – 04:11 CARMA platform, CAR therapy in oncology – 09:07 Cell therapy programmes – business model – 16:12 Revenue potential across multiple applications – 19:15 Expected news flow […]
MaxCyte (MXCT) presentation at ShareSoc July 2018
Driving the next generation of cell-based medicines
By Doug Doerfler – Founder, President & CEO
Introduction – 00:23
Background and what MaxCyte does – 02:41
Business model – 04:11
CARMA platform, CAR therapy in oncology – 09:07
Cell therapy programmes – business model – 16:12
Revenue potential across multiple applications – 19:15
Expected news flow – 21:36
Summary & outlook – 22:18
2017 financial highlights – 22:50
Q&A – 23:45
You might be interested in
0
03:55
